SG11201407628UA - Ribosomal polynucleotides and related expression systems - Google Patents
Ribosomal polynucleotides and related expression systemsInfo
- Publication number
- SG11201407628UA SG11201407628UA SG11201407628UA SG11201407628UA SG11201407628UA SG 11201407628U A SG11201407628U A SG 11201407628UA SG 11201407628U A SG11201407628U A SG 11201407628UA SG 11201407628U A SG11201407628U A SG 11201407628UA SG 11201407628U A SG11201407628U A SG 11201407628UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- jolla
- torrey pines
- pines road
- california
- Prior art date
Links
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 210000003705 ribosome Anatomy 0.000 title abstract 2
- 108020004463 18S ribosomal RNA Proteins 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- WVIUOSJLUCTGFK-UHFFFAOYSA-N Pactamycin Natural products CC=1C=CC=C(O)C=1C(=O)OCC1(O)C(O)(C)C(C(O)C)(NC(=O)N(C)C)C(N)C1NC1=CC=CC(C(C)=O)=C1 WVIUOSJLUCTGFK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- WVIUOSJLUCTGFK-JUJPXXQGSA-N pactamycin Chemical compound N([C@H]1[C@H](N)[C@@]([C@@]([C@]1(COC(=O)C=1C(=CC=CC=1C)O)O)(C)O)(NC(=O)N(C)C)[C@@H](O)C)C1=CC=CC(C(C)=O)=C1 WVIUOSJLUCTGFK-JUJPXXQGSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261649453P | 2012-05-21 | 2012-05-21 | |
| US201361778194P | 2013-03-12 | 2013-03-12 | |
| PCT/US2013/042061 WO2013177191A1 (fr) | 2012-05-21 | 2013-05-21 | Polynucléotides ribosomiques et systèmes d'expression associés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407628UA true SG11201407628UA (en) | 2014-12-30 |
Family
ID=48577911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407628UA SG11201407628UA (en) | 2012-05-21 | 2013-05-21 | Ribosomal polynucleotides and related expression systems |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9359616B2 (fr) |
| EP (1) | EP2852666B1 (fr) |
| JP (1) | JP2015519899A (fr) |
| KR (1) | KR20150016336A (fr) |
| CN (1) | CN104540944A (fr) |
| AU (1) | AU2013266461A1 (fr) |
| CA (1) | CA2873447A1 (fr) |
| SG (1) | SG11201407628UA (fr) |
| WO (1) | WO2013177191A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7667571B2 (ja) * | 2019-11-25 | 2025-04-23 | 国立研究開発法人理化学研究所 | 非リボソームｒｎａ含有試料の製造方法 |
| CN115236245A (zh) * | 2022-09-21 | 2022-10-25 | 首都医科大学附属北京朝阳医院 | 一种血清同型半胱氨酸的测量方法、候选标准物质及制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
| US5321131A (en) | 1990-03-08 | 1994-06-14 | Hybridon, Inc. | Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling |
| US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| DK51092D0 (da) | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
| US5700922A (en) | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| ATE162198T1 (de) | 1992-07-27 | 1998-01-15 | Hybridon Inc | Oligonukleotid alkylphosphonothiate |
| AU684748B2 (en) | 1993-01-21 | 1998-01-08 | Hybridon, Inc. | Foldback triplex-forming oligonucleotides |
| US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
| US5955599A (en) | 1995-06-01 | 1999-09-21 | Hybridon, Inc. | Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages |
| US6140482A (en) | 1995-06-01 | 2000-10-31 | Hybridon, Inc. | Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same |
| US5962674A (en) | 1995-06-01 | 1999-10-05 | Hybridon, Inc. | Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages |
| US5614622A (en) | 1995-06-01 | 1997-03-25 | Hybridon, Inc. | 5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses |
| US5637683A (en) | 1995-07-13 | 1997-06-10 | Cornell Research Foundation, Inc. | Nucleic acid analog with amide linkage and method of making that analog |
| US5652356A (en) | 1995-08-17 | 1997-07-29 | Hybridon, Inc. | Inverted chimeric and hybrid oligonucleotides |
| US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
| WO1998008858A1 (fr) | 1996-08-26 | 1998-03-05 | Hybridon, Inc. | Reactifs ameliores et procede de synthese d'oligonucleotides contenant des liaisons internucleosides phosphorodithioate |
| US5886165A (en) | 1996-09-24 | 1999-03-23 | Hybridon, Inc. | Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments |
| US5739314A (en) | 1997-04-25 | 1998-04-14 | Hybridon, Inc. | Method for synthesizing 2'-O-substituted pyrimidine nucleosides |
| DE60029314T2 (de) | 1999-03-24 | 2007-07-12 | Exiqon A/S | Verbesserte Synthese für -2.2.1. I Bicyclo-Nukleoside |
| KR20010001577A (ko) | 1999-06-07 | 2001-01-05 | 윤종용 | 고분자 광산발생제를 이용한 올리고펩티드 핵산 탐침의 제조방법 |
| AU6629200A (en) | 1999-08-25 | 2001-03-19 | Philip P Garner | Alpha-helical peptide nucleic acid alpha-pna |
| IL144082A0 (en) | 2000-07-14 | 2002-05-23 | Medical Res Council | Crystal structure of antibiotics bound to the 30s ribosome and its use |
| US6455308B1 (en) | 2001-08-01 | 2002-09-24 | Isis Pharmaceuticals, Inc. | Antisense modulation of serum amyloid A4 expression |
-
2013
- 2013-05-21 KR KR1020147035752A patent/KR20150016336A/ko not_active Withdrawn
- 2013-05-21 WO PCT/US2013/042061 patent/WO2013177191A1/fr not_active Ceased
- 2013-05-21 JP JP2015514124A patent/JP2015519899A/ja active Pending
- 2013-05-21 CA CA2873447A patent/CA2873447A1/fr not_active Abandoned
- 2013-05-21 EP EP13727742.2A patent/EP2852666B1/fr not_active Not-in-force
- 2013-05-21 CN CN201380037706.9A patent/CN104540944A/zh active Pending
- 2013-05-21 AU AU2013266461A patent/AU2013266461A1/en not_active Abandoned
- 2013-05-21 US US13/899,284 patent/US9359616B2/en not_active Expired - Fee Related
- 2013-05-21 SG SG11201407628UA patent/SG11201407628UA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2873447A1 (fr) | 2013-11-28 |
| US9359616B2 (en) | 2016-06-07 |
| AU2013266461A1 (en) | 2014-12-11 |
| EP2852666B1 (fr) | 2016-11-23 |
| WO2013177191A1 (fr) | 2013-11-28 |
| EP2852666A1 (fr) | 2015-04-01 |
| US20130309682A1 (en) | 2013-11-21 |
| KR20150016336A (ko) | 2015-02-11 |
| CN104540944A (zh) | 2015-04-22 |
| JP2015519899A (ja) | 2015-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201407505XA (en) | Aptamer-based multiplexed assays | |
| SG11201407486PA (en) | Compositions and methods for modulating utrn expression | |
| SG11201804161VA (en) | Compositions comprising bacterial strains | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201903830TA (en) | Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies | |
| SG11201408780XA (en) | Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201810611YA (en) | Coumarin compounds and their uses as fluorescent labels | |
| SG11201407802WA (en) | Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy | |
| SG11201906553TA (en) | Methods and reagents for synthesising polynucleotide molecules | |
| SG11201808014SA (en) | Compositions, devices, and methods for cell separation | |
| SG11201407483YA (en) | Compositions and methods for modulating smn gene family expression | |
| SG11201804211YA (en) | Compositions comprising bacterial strains | |
| SG11201907820SA (en) | Inhibitors of (alpha-v)(beta-6) integrin | |
| SG11201407564TA (en) | St2 antigen binding proteins | |
| SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201900744SA (en) | Fc engineered anti-tnfr superfamily member antibodies having enhanced agonistic activity and methods of using them | |
| SG11201803703UA (en) | Anti-complement factor c1q fab fragments and uses thereof | |
| SG11201407907XA (en) | Apparatus and method for film formation | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201403106SA (en) | Anti-phf-tau antibodies and their uses | |
| SG11201900883UA (en) | Combination treatment for hematological cancers | |
| SG11201809764XA (en) | Humanized anti-il-1r3 antibodies | |
| SG11201909708VA (en) | Methods and antibodies for diabetes-related applications |